2013
DOI: 10.1097/rlu.0b013e3182a20153
|View full text |Cite
|
Sign up to set email alerts
|

Proposal of a New 18F-FDG PET/CT Predictor of Response in Rectal Cancer Treated by Neoadjuvant Chemoradiation Therapy and Comparison With PERCIST Criteria

Abstract: FDG-PET/CT scan is an accurate tool to predict preoperatively the response to CRT in LARC patients. The novel proposed criterion (PREDIST) seems to be helpful to discriminate responder by nonresponder patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 16 publications
0
15
0
Order By: Relevance
“…19 It would be desirable to assess treatment response using functional response criteria such as PET response criteria in solid tumors 19 or PET residual disease in solid tumor. 20 However, posttreatment PET/CT is not routinely performed at our institution, and it has been shown that in metastatic colorectal cancer at least, metabolic response correlates well with size-based radiological response. 21 A further confounding factor is that a proportion of our patients underwent chemotherapy up to 3 months before the FDG PET/CT used to derive the metabolic parameters used in this study.…”
Section: Discussionmentioning
confidence: 99%
“…19 It would be desirable to assess treatment response using functional response criteria such as PET response criteria in solid tumors 19 or PET residual disease in solid tumor. 20 However, posttreatment PET/CT is not routinely performed at our institution, and it has been shown that in metastatic colorectal cancer at least, metabolic response correlates well with size-based radiological response. 21 A further confounding factor is that a proportion of our patients underwent chemotherapy up to 3 months before the FDG PET/CT used to derive the metabolic parameters used in this study.…”
Section: Discussionmentioning
confidence: 99%
“…SUL mean of the liver is usually measured by placing a spherical volume of interest (VOI) in the right lobe of liver. Liver SUV mean has also been utilized as normalization factor in PET derived quantitative therapy response formulations, which were further adapted to assess residual disease in colorectal malignancy [3,4]. In our previous work[5], we demonstrated that Liver SUL mean has almost perfect inter-reader reliability, regardless of whether the volume of interest (VOI) is placed at the upper, lower, or portal vein level of the right lobe of the liver and the inter reader variability is least in the upper aspect of the right lobe of the liver.…”
Section: Introductionmentioning
confidence: 99%
“…There has been need for standardization of 18 34,35 In the future, these newly proposed criteria for tumor response and volume segmentation system should be used.…”
Section: Discussionmentioning
confidence: 99%